Invesco
KITE

Invesco’s Kite Pharma, Inc. KITE Stock Holding History

Invesco’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,549
Closed -$1.9M – 3722
2017
Q3 		$1.9M Sell
10,549
-98,238
-90% -$13.7M ﹤0.01% 2615
2017
Q2 		$11.3M Buy
108,787
+98,632
+971% +$8.05M ﹤0.01% 1479
2017
Q1 		$797K Buy
10,155
+5,649
+125% +$349K ﹤0.01% 3150
2016
Q4 		$202K Sell
4,506
-24
-0.5% -$1.18K ﹤0.01% 3557
2016
Q3 		$253K Buy
+4,530
New +$252K ﹤0.01% 3481
2016
Q1 		– Sell
-104,395
Closed -$6.43M – 3810
2015
Q4 		$6.43M Buy
104,395
+9,717
+10% +$684K ﹤0.01% 1711
2015
Q3 		$5.27M Buy
94,678
+94,590
+107,489% +$5.95M ﹤0.01% 1843
2015
Q2 		$5K Buy
+88
New +$5.02K ﹤0.01% 4257

Invesco's KITE Position: Q4 2017 in Review

Invesco sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 10,549 shares — an estimated $1.9M sold.

Invesco first reported a position in KITE in Q2 2015 and held it in 8 quarters. The position peaked at $11.3M in Q2 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Invesco reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Invesco sold 10,549 Kite Pharma, Inc. shares in Q4 2017, an estimated $1.9M.
  • Invesco first reported a position in Kite Pharma, Inc. in Q2 2015 and held it in 8 quarters.
  • Invesco's Kite Pharma, Inc. position peaked at $11.3M in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Invesco's 13F filing for Q4 2017, filed 14 Feb 2018.